Forum: Clinical Trials
09-21-2013, 11:59 AM
|
Replies: 0
Views: 17,722
First line Treatment - Perjeta for MBC
322 study sites - internationally (outside of the US)
A Study of Pertuzumab in Combination With Herceptin (Trastuzumab) and A Taxane in First-Line Treatment in Patients With HER2-Positive...
|